ID: ALA3973578

Max Phase: Preclinical

Molecular Formula: C19H22N2OS

Molecular Weight: 326.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cnc(SCC(=O)N2CCCc3cccc(C)c32)cc1C

Standard InChI:  InChI=1S/C19H22N2OS/c1-13-6-4-7-16-8-5-9-21(19(13)16)18(22)12-23-17-10-14(2)15(3)11-20-17/h4,6-7,10-11H,5,8-9,12H2,1-3H3

Standard InChI Key:  KTHJQHSQBKPZKR-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily V member 3 542 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 326.47Molecular Weight (Monoisotopic): 326.1453AlogP: 4.08#Rotatable Bonds: 3
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.51CX LogP: 4.47CX LogD: 4.47
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -1.71

References

1.  (2015)  Compounds of modulating TRPV3 function, 

Source

Source(1):